FiercePharma1d
Gearing up to challenge Lilly in obesity, Kailera picks Zepbound brand leader as new commercial chief
The biotech has named Jamie Coleman its chief commercial officer, per a Monday announcement, putting her in charge of the ...
Pennsylvania woman speaks out after Independence Blue Cross drops weight loss drug coverage
A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.
Forbes27d
Lilly’s Obesity Drug Zepbound To Be Key 2025 Health Cost Driver
In this photo is a Zepbound injection pen arranged in the ... health programs that cover it this year. Already, GLP-1 weight loss prescriptions Wegovy, Rybelsus and Saxenda—along with Ozempic ...
STAT11d
High-dose Wegovy leads to substantial weight loss in trial, but falls short of Zepbound
A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...
Medicine Buffalo15d
UB pharmacy professor discusses pros and cons of popular weight-loss drugs
Nicole Albanese, PharmD, discusses the science behind weight-loss drugs, their potential to treat other addictions as well as possible dangers.
Lilly Shares on Track for Worst Day Since 2021 After Downbeat Zepbound Sales Forecast
The company's shares were trading at $740.80, on track for their worst single-day decline in nearly four years. Lilly's stock went on a tear in the beginning in 2023 as investors bet on the drug's ...
phillyvoice.com6d
Ozempic and Wegovy are helping many Americans lose weight, but they also may have other beneficial uses
also includes Wegovy and Zepbound. GLP-1s were developed to treat diabetes, but they have become popular weight-loss medications. MORE: In Kensington, outreach workers give out food, clothing and ...